title: [Melanoma during latanoprost therapy: three cases].
authors.forename: E
authors.initials: E
authors.lastname: Estève
authors.forename: F
authors.initials: F
authors.lastname: Beau-Salinas
authors.forename: L
authors.initials: L
authors.lastname: Estève
authors.forename: J-M
authors.initials: JM
authors.lastname: Lemacon
authors.forename: E
authors.initials: E
authors.lastname: Autret-Leca
authors.forename: H
authors.initials: H
authors.lastname: Le Louet
authors.forename: R
authors.initials: R
authors.lastname: Hocine
authors.forename: P
authors.initials: P
authors.lastname: Wolkenstein
authors.forename: J-L
authors.initials: JL
authors.lastname: Plaquet
mesh_terms: D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002830:Choroid Neoplasms / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D000077338:Latanoprost; D008545:Melanoma / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost